Cambridge Healthtech Institute’s Inaugural

Preclinical and Translational Immuno-Oncology

Advanced Models of Immuno-Oncology and Preclinical Strategies in Preparation for Clinical Trials

21-22 March 2019

 

Modelling the immune system and its response to cancer sets a particularly difficult challenge. The different cell types required, heterogeneity of tumours and the signaling pathways involved, mean that multiple advanced models are required to justify clinical trials. But which ones do you choose? At the Preclinical and Translational Immuno-Oncology conference, we will delve deeper into the advantages and disadvantages of each model and the strategies employed to help translate positive results to clinical trials. Models to be discussed include humanized mice models, syngeneic and xenograph models, 3D models and organoids, plus many more.

 

Coverage will include, but is not limited to:

 

  • Humanized Mice Models
  • Syngeneic and Xenograph Models
  • 3D Models and Organoids
  • Translational Strategies
  • Tumour Microenvironment
  • Novel Targets and Biomarkers

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is 10 September 2018.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Joel Hornby, BSc Hons

Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781 247 1816
Email: jhornby@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286
Email: reymael@healthtech.com